Nantahala Capital Management - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$6,945,000
+52.6%
1,477,563
+8.8%
0.21%
+50.7%
Q1 2019$4,550,000
+25.9%
1,358,1000.0%0.14%
+27.9%
Q4 2018$3,613,000
+1.5%
1,358,100
+113.6%
0.11%
+15.6%
Q3 2018$3,561,000635,8450.10%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders